齐齐哈尔医学院学报
齊齊哈爾醫學院學報
제제합이의학원학보
JOURNAL OF QIQIHAR MEDICAL COLLEGE
2015年
15期
2214-2215
,共2页
恩替卡韦%干扰素%乙型肝炎
恩替卡韋%榦擾素%乙型肝炎
은체잡위%간우소%을형간염
Entecavir%Interferon%Hepatitis B
目的:探讨恩替卡韦联合干扰素治疗HBV的临床疗效。方法比较分析60例HBV患者在联合应用恩替卡韦和干扰素治疗24周后,在HBeAg、HBVDNA和ALT 等方面的临床疗效。结果HBVDNA转阴率86%,HBeAg转阴率43%,ALT复常率90%(P<0.05)。结论恩替卡韦联合干扰素在治疗乙型肝炎方面远期效果好,疗效肯定。
目的:探討恩替卡韋聯閤榦擾素治療HBV的臨床療效。方法比較分析60例HBV患者在聯閤應用恩替卡韋和榦擾素治療24週後,在HBeAg、HBVDNA和ALT 等方麵的臨床療效。結果HBVDNA轉陰率86%,HBeAg轉陰率43%,ALT複常率90%(P<0.05)。結論恩替卡韋聯閤榦擾素在治療乙型肝炎方麵遠期效果好,療效肯定。
목적:탐토은체잡위연합간우소치료HBV적림상료효。방법비교분석60례HBV환자재연합응용은체잡위화간우소치료24주후,재HBeAg、HBVDNA화ALT 등방면적림상료효。결과HBVDNA전음솔86%,HBeAg전음솔43%,ALT복상솔90%(P<0.05)。결론은체잡위연합간우소재치료을형간염방면원기효과호,료효긍정。
Objective To explore the clinical effects of Entecavir combined interferon treatment for HBV virus.Methods Compared and analyzed clinical effects of Entecavir combined interferon on 60 CHB patients in HBeAg-positive, HBVDNA and ALT after 24 weeks.Results HBVDNA overcast rate 86% , HBeAg overcast rate 43%,ALT liver function recovery rate was 90%.Conclusions The forward effect of entecavir combined interferon is good , has affirmative curative effect .